SCHEMBL27089959

SCHEMBL27089959

Cc1cc(O)nc(SCC(=O)c2cccc3ccccc23)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.53
▸ HPGD P15428 6/20 0.53
▸ ALDH1A1 P00352 4/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ LMNA P02545 3/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ ALPL P05186 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ ALPI P09923 1/20 0.48
▸ ALPG P10696 1/20 0.48
▸ PLAA Q9Y263 1/20 0.48
▸ HTT P42858 2/20 0.48
▸ HSP90AA1 P07900 1/20 0.48
▸ GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29392686 0.76 HDAC6 (0.68) MAPTALDH1A1LMNACYP1A2CYP2C9
SCHEMBL13401534 0.73 SMN1; SMN2 (0.67) MAPTHPGDALDH1A1MEN1KMT2A
SCHEMBL11830543 0.72 ALDH1A1 (0.68) MAPTHPGDALDH1A1MEN1KMT2A
SCHEMBL10350929 0.72 ALDH1A1 (0.64) MAPTHPGDALDH1A1MEN1KMT2A
SCHEMBL15731791 0.71 HSD17B10 (0.65) MAPTHPGDALDH1A1MEN1KMT2A
SCHEMBL13401667 0.69 HDAC3 (0.61) MAPTHPGDALDH1A1MEN1KMT2A
SCHEMBL11837828 0.69 ALOX15 (0.56) HPGDALDH1A1LMNAHSD17B10GAA
SCHEMBL20068030 0.68 SIRT2 (0.72) MAPTMEN1KMT2ALMNACYP3A4
SCHEMBL1520968 0.68 SMN1; SMN2 (0.57) MAPTHPGDALDH1A1KMT2ALMNA
Hydrochloric Acid SCHEMBL844383 0.68 POLB (0.39) MAPTHPGDALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240050471-A1 METHODS FOR ACTIVATING IMMUNE CELLS AND TREATING OCULAR NEOVASCULARIZATION WASHINGTON UNIVERSITY (US) 2024-02-15 — — US disclosed
Send feedback